Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update

References

• Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, et al. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005–2010. BMC Infect Dis. 2015;15:362. doi: 10.1186/s12879-015-1071-0.10.1186/s12879-015-1071-0
   PubMed Web of Science ®Google Scholar
• Esposito S, Noviello S, Leone S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis. 2016;29:109–15.10.1097/QCO.0000000000000239
   PubMed Web of Science ®Google Scholar
• Esposito S, Bassetti M, Borrè S, Bouza E, Dryden M, Fantoni M, et al. Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy. J Chemother. 2011;23:251–62.10.1179/joc.2011.23.5.251
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Petta E, Noviello S, Iori I. Skin and soft tissue infections: classification and epidemiology. Infez Med. 2009;17(Suppl. 4):6–17.
   PubMedGoogle Scholar
• Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:147–59.10.1093/cid/ciu444
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Guidance for industry. Acute bacterial skin and skin structure infections: developing drugs for treatment. Silver Spring (MD): US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2013.
   Google Scholar
• Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, et al. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect. 2016;22:S27–36.10.1016/S1198-743X(16)30095-7
   PubMed Web of Science ®Google Scholar
• Sanchez-Porto A, Martin-Gomez M, Casanova-Roman M, Casas-Ciria J, Nacle B. Necrotizing soft-tissue infections in a general hospital. Infez Med. 2010;18(3):191–2.
   PubMedGoogle Scholar
• Menichetti F. Skin and skin tissue infections: main clinical patterns/pictures. Infez Med. 2009;Suppl. 4:30–6.
   Google Scholar
• Esposito S, Bassetti M, Bonnet E, Bouza E, Chan M, De Simone G, et al. Hot topics in the diagnosis and management of skin and soft-tissue infections. Int J Antimicrob Agents. 2016;48(1):19–26.10.1016/j.ijantimicag.2016.04.011
   PubMed Web of Science ®Google Scholar
• Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(A). Clin Infect Dis. 2013;57(4):e121–2.10.1093/cid/cit278
   Web of Science ®Google Scholar
• Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, et al. Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2013;57(4):485–8.10.1093/cid/cit441
   PubMed Web of Science ®Google Scholar
• Esposito S, De Simone G, Gioia R, Noviello S, Pagliara D, Campitiello N, et al. Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of Skin and Soft Tissue Infections (SSTIs). J Chemother. 2016;47:1–5.10.1080/1120009X.2016.1205309
   Google Scholar
• Kallstrom G. Are quantitative bacterial wound cultures useful? J Clin Microbiol. 2014;52:2753–6.10.1128/JCM.00522-14
   PubMed Web of Science ®Google Scholar
• Johnson KE, Kiyatkin DE, An AT, Riedel S, Melendez J, Zenilman JM. PCR offers no advantage over culture for microbiologic diagnosis in cellulitis. Infection. 2012;40:537–41.10.1007/s15010-012-0289-7
   PubMed Web of Science ®Google Scholar
• Bouchiat C, Bes M, Bouveyron C, Vandenesch F, Tristan A. Evaluation of the R-Biopharm RIDA®GENE Panton-Valentine leukocidin (PVL) kit for the detection of Staphylococcus aureus PVL from pus samples. Eur J Clin Microbiol Infect Dis. 2015;34(9):1905–8.10.1007/s10096-015-2431-9
   PubMed Web of Science ®Google Scholar
• Saeed K, Ahmad N, Dryden M, Cortes N, Marsh P, Sitjar A, et al. Oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK. Infection. 2014;42:843–7.10.1007/s15010-014-0641-1
   PubMed Web of Science ®Google Scholar
• Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a US population: a retrospective population-based study. BMC Infect Dis. 2013;13(1):173. doi:10.1186/1471-2334-13-252.10.1186/1471-2334-13-252
   PubMed Web of Science ®Google Scholar
• Ascione T, Pagliano P, Mariconda M, Rotondo R, Balato G, Toro A, et al. Factors related to outcome of early and delayed prosthetic joint infections. J Infect. 2015 Jan;70(1):30–6.10.1016/j.jinf.2014.07.008
   PubMed Web of Science ®Google Scholar
• Testa A, Giannuzzi R, De Biasio V. Case report: role of bedside ultrasonography in early diagnosis of myonecrosis rapidly developed in deep soft tissue infections. J Ultrasound. 2015;19(3):217–21.
   PubMed Web of Science ®Google Scholar
• Gottlieb J, Mailhot T, Chilstrom M. Point-of-care ultrasound diagnosis of deep space hand infection. J Emerg Med. 2016;50(3):458–61.10.1016/j.jemermed.2015.09.012
   PubMed Web of Science ®Google Scholar
• Iverson K, Haritos D, Thomas R, Kannikeswaran N. The effect of bedside ultrasound on diagnosis and management of soft tissue infections in a pediatric ED. Am J Emerg Med. 2012;30(8):1347–51.10.1016/j.ajem.2011.09.020
   PubMed Web of Science ®Google Scholar
• Gaspari RJ, Blehar D, Polan D, Montoya A, Alsulaibikh A, Liteplo A. The Massachusetts Abscess rule: a clinical decision rule using ultrasound to identify Methicillin-resistant Staphylococcus aureus in skin abscesses. Acad Emerg Med. 2014;21(5):558–67.10.1111/acem.12379
   PubMed Web of Science ®Google Scholar
• Adhikari S, Blaivas M. Sonography first for subcutaneous abscess and cellulitis evaluation. J Ultrasound Med. 2012;31(10):1509–12.10.7863/jum.2012.31.10.1509
   PubMed Web of Science ®Google Scholar
• Signore A, Glaudemans AW, Galli F, Rouzet F. Imaging infection and inflammation. Biomed Res Int. 2015;2015:615150.
   PubMed Web of Science ®Google Scholar
• Kiriakis KP, Tadros A, Dimou A, Karamanou M, Banaka F, Alexoudi I. Case detection rates of impetigo by gender and age. Infez Med. 2012;20(2):105–7.
   PubMedGoogle Scholar
• Romani L, Koroivueta J, Steer AC, Kama M, Kaldor JM, Wand H, et al. Scabies and impetigo prevalence and risk factors in Fiji: a national survey. PLoS Negl Trop Dis. 2015;9(3):e0003452.10.1371/journal.pntd.0003452
   PubMed Web of Science ®Google Scholar
• Bowen AC, Mahé A, Hay RJ, Andrews RM, Steer AC, Tong SY, et al. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLOS One. 2015;10(8):e0136789.10.1371/journal.pone.0136789
   PubMed Web of Science ®Google Scholar
• Yeoh DK, Bowen AC, Carapetis JR. Impetigo and scabies – disease burden and modern treatment strategies. J Infect. 2016;72:S61–7.10.1016/j.jinf.2016.04.024
   PubMed Web of Science ®Google Scholar
• Bowen AC, Tong SY, Chatfield MD, Carapetis JR. The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage. BMC Infect Dis. 2014;14:139.10.1186/s12879-014-0727-5
   PubMed Web of Science ®Google Scholar
• Bernard P, Jarlier V, Santerre-Henriksen A. Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections. Ann Dermatol Venereol. 2008;135(1):13–19.10.1016/j.annder.2007.06.004
   PubMed Web of Science ®Google Scholar
• Bangert S, Levy M, Hebert AA. Bacterial resistance and impetigo treatment trends: a review. Pediatr Dermatol. 2012;29(3):243–8.10.1111/j.1525-1470.2011.01700.x
   PubMed Web of Science ®Google Scholar
• Tong SY, Varrone L, Chatfield MD, Beaman M, Giffard PM. Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012. Epidemiol Infect. 2015;143(7):1519–23.10.1017/S0950268814002611
   PubMed Web of Science ®Google Scholar
• Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Phys. 2014;90(4):229–35.
   PubMed Web of Science ®Google Scholar
• Pereira LB. Impetigo – review. An Bras Dermatol. 2014;89(2):293–9.10.1590/abd1806-4841.20142283
   PubMed Web of Science ®Google Scholar
• Yamasaki O, Tristan A, Yamaguchi T, Sugai M, Lina G, Bes M, et al. Distribution of the exfoliative toxin D gene in clinical Staphylococcus aureus isolates in France. Clin Microbiol Infect. 2006;12(6):585–8.10.1111/j.1469-0691.2006.01410.x
   PubMed Web of Science ®Google Scholar
• Raya-Cruz M, Ferullo I, Arrizabalaga-Asenjo M, Nadal-Nadal A, Díaz-Antolín MP, Garau-Colom M, et al. Skin and soft-tissue infections in hospitalized patients: epidemiology, microbiological, clinical and prognostic factors. Enferm Infecc Microbiol Clin. 2014;32(3):152–9.10.1016/j.eimc.2013.03.004
   PubMed Web of Science ®Google Scholar
• Rossolini GM, Stefani S. Aetiology, resistance and diagnostic techniques in skin and skin structure infections. Infez Med. 2009;17(Suppl. 4):18–29.
   PubMedGoogle Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, Albrecht V, Limbago B, et al. Prevalence of methicillin-resistant staphylococcus aureus as an aetiology of community-acquired pneumonia. Clin Infect Dis. 2012;54(8):1126–33.10.1093/cid/cis022
   PubMed Web of Science ®Google Scholar
• Taira BR, Singer AJ, Thode HC Jr, Lee CC. National epidemiology of cutaneous abscesses: 1996 to 2005. Am J Emerg Med. 2009;27(3):289–92.10.1016/j.ajem.2008.02.027
   PubMed Web of Science ®Google Scholar
• Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J infect Dis. 2004;189:1565–73.10.1086/jid.2004.189.issue-9
   PubMed Web of Science ®Google Scholar
• Wiese-Posselt M, Heuck D, Draeger A, Mielke M, Witte W, Ammon A, et al. Successful termination of a furunculosis Outbreak Due to lukS-lukF-Positive, Methicillin-Susceptible Staphylococcus aureus in a German Village by Stringent Decolonization, 2002–2005. Clin Infect Dis. 2007;44(11):e88–95.10.1086/517503
   PubMed Web of Science ®Google Scholar
• Golding GR, Levett PN, McDonald RR, Irvine J, Nsungu M, Woods S, et al. A comparison of risk factors associated with community-associated methicillin-resistant and -susceptible Staphylococcus aureus infections in remote communities. Epidemiol Infect. 2010;138(5):730–7.10.1017/S0950268809991488
   PubMed Web of Science ®Google Scholar
• Tinelli M, Monaco M, Vimercati M, Ceraminiello A, Pantosti A. Methicillin-susceptible Staphylococcus aureus in skin and soft tissue infections, Northern Italy. Emerg Infect Dis. 2009;15(2):250–7.10.3201/eid1502.080010
   PubMed Web of Science ®Google Scholar
• Hsiang MS, Shiau R, Nadle J, Chan L, Lee B, Chambers HF, et al. Epidemiologic similarities in pediatric community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus in the San Francisco Bay Area. J Pediatric Infect Dis Soc. 2012;1(3):200–11.10.1093/jpids/pis061
   PubMedGoogle Scholar
• Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA. 2001;286(10):1201–5.10.1001/jama.286.10.1201
   PubMed Web of Science ®Google Scholar
• Robert E, Carrie E. Dog and cat bites. Am Fam Physician. 2014;90(4):239–43.
   PubMed Web of Science ®Google Scholar
• Rothe K, Tsokos M, Handrick W. Animal and human bite wounds. Dtsch Arztebl Int. 2015;112(25):433–42.
   PubMed Web of Science ®Google Scholar
• Garau J, Ostermann H, Medina J, Ávila M, McBride K, Blasi F, et al. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study. Clin Microbiol Infect. 2013;19(9):E377–85.10.1111/1469-0691.12235
   PubMed Web of Science ®Google Scholar
• Ban KA, Minei JP, Laronga C, Harbrecht BG, Jensen EH, Fry DE, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines. J Am Coll Surg. 2016;19. pii: S1072-7515(16)31563-0.
   Google Scholar
• Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):88–99.10.1017/ice.2015.249
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986–April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control. 1996;24:380–8.
   PubMed Web of Science ®Google Scholar
• Sganga G, Tascini C, Sozio E, Carlini M, Chirletti P, Cortese F, et al. Focus on the prophylaxis, epidemiology and therapy of methicillin-resistant Staphylococcus aureus surgical site infections and a position paper on associated risk factors: the perspective of an Italian group of surgeons. World J Emerg Surg. 2016;11:267.  doi: 10.1186/s13017-016-0086-110.1186/s13017-016-0086-1
   Web of Science ®Google Scholar
• Iori I, Pizzini AM, Arioli D, Favali D, Leone MC. Infected pressure ulcers: evaluation and management. Infez Med. 2009;17(Suppl. 4):88–94.
   PubMedGoogle Scholar
• Singer AJ, Talan DA. Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus. N Engl J Med. 2014;370:1039–47.10.1056/NEJMra1212788
   PubMed Web of Science ®Google Scholar
• Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016;316:325–37.10.1001/jama.2016.8825
   PubMed Web of Science ®Google Scholar
• Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010;16(6):729–34.10.1111/j.1469-0691.2009.02906.x
   PubMed Web of Science ®Google Scholar
• Soo JK, Bicanic TA, Heenan S, Mortimer PS. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br J Dermatol. 2008;158:1350–3.10.1111/j.1365-2133.2007.08423.x
   PubMed Web of Science ®Google Scholar
• Agarwal V, Chauhan S, Gupta RK. Pyomyositis. Neuroimaging Clin N Am. 2011;21(4):975–83.10.1016/j.nic.2011.07.011
   PubMed Web of Science ®Google Scholar
• García C, Hallin M, Deplano A, Denis O, Sihuincha M, de Groot R, et al. Staphylococcus aureus causing tropical pyomyositis, Amazon Basin, Peru. Emerg Infect Dis. 2013;19(1):123–5.10.3201/eid1901.120819
   PubMed Web of Science ®Google Scholar
• Borschitz T, Schlicht S, Siegel E, Hanke E, von Stebut E. Improvement of a clinical score for necrotizing fasciitis: ‘Pain Out of Proportion’ and high CRP levels aid the diagnosis. PLoS One. 2015;10(7):e0132775.10.1371/journal.pone.0132775
   PubMed Web of Science ®Google Scholar
• Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;29(1):36.
   Google Scholar
• Tsai YH, Shen SH, Yang TY, Chen PH, Huang KC, Lee MS. Monomicrobial Necrotizing Fasciitis Caused by Aeromonas hydrophila and Klebsiella pneumoniae. Med Princ Pract. 2015;24(5):416–23.10.1159/000431094
   PubMed Web of Science ®Google Scholar
• Stevens DL, Aldape MJ, Bryant AE. Life-threatening clostridial infections. Anaerobe. 2012;18(2):254–9.10.1016/j.anaerobe.2011.11.001
   PubMed Web of Science ®Google Scholar
• Korkut M, İçöz G, Dayangaç M, Akgün E, Yeniay L, Erdoğan Ö, et al. Outcome analysis in patients with Fournier’s gangrene. Report of 45 cases. Dis Colon Rectum. 2003;46(5):649–52.10.1007/s10350-004-6626-x
   PubMed Web of Science ®Google Scholar
• Mathew D, Sorensen MD, Krieger JN. Fournier’s gangrene: epidemiology and outcomes in the general US population. Urol Int. 2016;97:249–59.
   PubMed Web of Science ®Google Scholar
• Bruketa T, Majerovic M, Augustin G. Rectal cancer and Fournier’s gangrene – current knowledge and therapeutic options. G World J Gastroenterol. 2015;21(30):9002–20.
   PubMed Web of Science ®Google Scholar
• Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's Gangrene. J Urol. 1995;154:89–92.
   PubMed Web of Science ®Google Scholar
• Adembri C, Novelli A. Pharmacokinetic and pharmacodynamic parameters of antimicrobials. Clin Pharmacokinet. 2009;48(8):517–28.10.2165/10895960-000000000-00000
   PubMed Web of Science ®Google Scholar
• Hahn AW, Jain R, Spach DH. New approaches to antibiotic use and review of recently approved antimicrobial agents. Med Clin North Am. 2016;100(4):911–26.10.1016/j.mcna.2016.03.012
   PubMed Web of Science ®Google Scholar
• Bamberger DM, Foxworth JW, Bridwell DL, Shain CS, Gerding DN. Extravascular antimicrobial distribution and the respective blood and urine concentrations in humans. Antibiotics in laboratory medicine Lorian. 5th ed., Chapter 16. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. p. 719–814.
   Google Scholar
• Novelli A, Conti S, Cassetta MI, Fallani S. Cephalosporins: a pharmacological update. Clin Microbiol Infect. 2000;6(Suppl. 3):50–2.10.1111/j.1469-0691.2000.tb02041.x
   PubMed Web of Science ®Google Scholar
• Novelli A, Cassetta MI, Fallani S, Periti P. Clinical pharmacokinetics and tissue penetration of ciprofloxacin after a single oral dose of 250 or 500 mg. In: Lode H, editors. Ciprofloxacin in clinical practice, new light on established and emerging uses. Berlin: Schwer Verlag; 1990. p. 81–6.
   Google Scholar
• Stoehr GP, Yu VL, Johnson JT, Antal EJ, Townsend RJ, Wagner R. Clindamycin pharmacokinetics and tissue penetration after head and neck surgery. Clin Pharm. 1988;7(11):820–4.
   PubMedGoogle Scholar
• Nicolau DP, Sun HK, Seltzer E, Buckwalter M, Dowell JA. Pharmacokinetics of dalbavancin in plasma and skin blister fluid. J Antimicrob Chemother. 2007;60(3):681–4.10.1093/jac/dkm263
   PubMed Web of Science ®Google Scholar
• Wise R, Gee T, Andrews JM, Dvorchik B, Marshall G. Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers. Antimicrob Agents Chemother. 2002;46(1):31–3.10.1128/AAC.46.1.31-33.2002
   PubMed Web of Science ®Google Scholar
• Laethem T, De Lepeleire I, McCrea J, Zhang J, Majumdar A, Musson D, et al. Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers. Antimicrob Agents Chemother. 2003;47(4):1439–42.10.1128/AAC.47.4.1439-1442.2003
   PubMed Web of Science ®Google Scholar
• Periti P, Rizzo M, Novelli A, Reali EF, Dami A, Boni S, et al. Pharmacokinetics and penetration into extravascular fluid of imipenem in patients with normal renal function. In: Berkarda B, Kuemmerle HP, editors. Progress in chemotherapy, antimicrobial section. Proceedings of the 15th International Congress of Chemotherapy, Istanbul; 1987 Jul 19–24; Vol. 1. Munich: Ecomed; 1987. p. 990–2.
   Google Scholar
• Zeitlinger MA, Traunmüller F, Abrahim A, Müller MR, Erdogan Z, Müller M, et al. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung. Int J Antimicrob Agents. 2007;29(1):44–50.10.1016/j.ijantimicag.2006.08.045
   PubMed Web of Science ®Google Scholar
• Gee T, Ellis R, Marshall G, Andrews J, Ashby J, Wise R. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother. 2001;45:1843–6.10.1128/AAC.45.6.1843-1846.2001
   PubMed Web of Science ®Google Scholar
• Jonsson TB, Nilsson TK, Breimer LH, Schneede J, Arfvidsson B, Norgren L. Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia. Eur J Clin Pharmacol. 2014;70(8):957–63.10.1007/s00228-014-1695-9
   PubMed Web of Science ®Google Scholar
• Novelli A, Ciuffi M, Reali UM, Mazzei T, Periti P. The suction blister technique as a tool in antimicrobial drug pharmacokinetics. Drugs Exptl Clin Res. 1983;9(7):555–9.
   Google Scholar
• Sahre M, Sabarinath S, Grant M, Seubert C, Deanda C, Prokocimer P, et al. Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers. Int J Antimicrob Agents. 2012;40(1):51–4.10.1016/j.ijantimicag.2012.03.006
   PubMed Web of Science ®Google Scholar
• Novelli A, Mazzei T, Reali EF, Mini E, Periti P. Clinical pharmacokinetics and tissue penetration of teicoplanin. Int J Clin Pharmacol Res. 1989;9(3):233–7.
   PubMedGoogle Scholar
• Wise R, Donovan IA, McNulty CA, Waldron R, Andrews JM. Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration. J Hosp Infect. 1986;7(Suppl. A):47–9.10.1016/0195-6701(86)90007-1
   PubMed Web of Science ®Google Scholar
• de Lalla F, Novelli A, Pellizzer G, Milocchi F, Viola R, Rigon A, et al. Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration. Antimicrob Agents Chemother. 1993;37(12):2693–8.10.1128/AAC.37.12.2693
   PubMed Web of Science ®Google Scholar
• Sun HK, Duchin K, Nightingale CH, Shaw JP, Seroogy J, Nicolau DP. Tissue penetration of telavancin after intravenous administration in healthy subjects. Antimicrob Agents Chemother. 2006;50(2):788–90.10.1128/AAC.50.2.788-790.2006
   PubMed Web of Science ®Google Scholar
• Sun HK, Ong CT, Umer A, Harper D, Troy S, Nightingale CH, et al. Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations. Antimicrob Agents Chemother. 2005;49(4):1629–32.10.1128/AAC.49.4.1629-1632.2005
   PubMed Web of Science ®Google Scholar
• Skhirtladze K, Hutschala D, Fleck T, Thalhammer F, Ehrlich M, Vukovich T, et al. Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother. 2006;50(4):1372–5.10.1128/AAC.50.4.1372-1375.2006
   PubMed Web of Science ®Google Scholar
• Falcone M, Russo A, Venditti M, Novelli A, Pai MP. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57(11):1568–76.
   PubMed Web of Science ®Google Scholar
• Burnham JP, Kirby JP, Kollef MH. Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review. Intensive Care Med. 2016 Oct 3. Review. PubMed PMID: 27699456.
   PubMed Web of Science ®Google Scholar
• Mazzei T, Novelli A, Arrigucci S. Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections. Infez Med. 2009;4:37–57.
   Google Scholar
• Montravers P, Snauwaert A, Welsch C. Current guidelines and recommendations for the management of skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2):131–8.10.1097/QCO.0000000000000242
   PubMed Web of Science ®Google Scholar
• Chamny S, Miron D, Lumelsky N, Shalev H, Gazal E, Keynan R, et al. Topical minocycline foam for the treatment of impetigo in children: results of a randomized, double-blind, phase 2 study. J Drugs Dermatol. 2016;15(10):1238–43.
   PubMed Web of Science ®Google Scholar
• Olaniyi R, Pozzi C, Grimaldi L, Bagnoli F. Staphylococcus aureus-associated skin and soft tissue infections: anatomical localization, epidemiology, therapy and potential prophylaxis. Curr Top Microbiol Immunol. 2016 Oct 16. [Epub ahead of print] PubMed PMID: 27744506.
   PubMedGoogle Scholar
• Davido B, Dinh A, Salomon J, Roux AL, Gosset-Woimant M, Pierre I, et al. Recurrent furunculosis: efficacy of the CMC regimen–skin disinfection (chlorhexidine), local nasal antibiotic (mupirocin), and systemic antibiotic (clindamycin). Scand J Infect Dis. 2013;45(11):837–41.10.3109/00365548.2013.810815
   PubMed Web of Science ®Google Scholar
• Gaspari RJ, Resop D, Mendoza M, Kang T, Blehar D. A randomized controlled trial of incision and drainage versus ultrasonographically guided needle aspiration for skin abscesses and the effect of methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2011;57:483–91.10.1016/j.annemergmed.2010.11.021
   PubMed Web of Science ®Google Scholar
• Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374(9):823–32.10.1056/NEJMoa1507476
   PubMed Web of Science ®Google Scholar
• Moran GJ, Fang E, Corey GR, Das AF, De Anda C, Prokocimer P. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis. 2014;14(8):696–705.
   PubMed Web of Science ®Google Scholar
• Falcone M, Concia E, Giusti M, Mazzone A, Santini C, Stefani S, et al. Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs. Intern Emerg Med. 2016;11(5):637–48.10.1007/s11739-016-1450-6
   PubMed Web of Science ®Google Scholar
• Ferreira A, Bolland MJ, Thomas MG. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas. Infection. 2016;44(5):607–15.10.1007/s15010-016-0895-x
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–92.10.1093/cid/cir034
   PubMed Web of Science ®Google Scholar
• Wilcox MH, Corey GR, Talbot GH, Thye D, Friedland D, Baculik T, et al. CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010;65(Suppl. 4):53–65.
   Google Scholar
• Corey R, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T, et al. CANVAS 1: the first phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010;65(Suppl. 4):41–51.
   Google Scholar
• Bassetti M, Baguneid M, Bouza E, Dryden M, Nathwani D, Wilcox M, et al. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect. 2014;20(Suppl. 4):3–18.
   PubMed Web of Science ®Google Scholar
• Canut A, Isla A, Rodríguez-Gascón A. Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skinstructure infections in patients with normal and impaired renal function. Int J Antimicrob Agents. 2015;45:399–405.10.1016/j.ijantimicag.2014.12.023
   PubMed Web of Science ®Google Scholar
• Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis. 2008;46:647–55.10.1086/526527
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Carnelutti A. New therapeutic options for skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2):99–108.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Fang E, Minassian SL, Prokocimer PG. Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the phase 3 ESTABLISH clinical trials. Antimicrob Agents Chemother. 2014;58:7198–204.10.1128/AAC.03509-14
   PubMed Web of Science ®Google Scholar
• Shorr AF, Lodise TP, Corey GR, De Anda C, Fang E, Das AF, et al. Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections. Antimicrob Agents Chemother. 2015;59:864–71.10.1128/AAC.03688-14
   PubMed Web of Science ®Google Scholar
• Montravers P, Bassetti M, Dupont H, Eckmann C, Heizmann WR, Guirao X, et al. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies. J Antimicrob Chemother. 2013;68(Suppl. 2):15–24.
   Web of Science ®Google Scholar
• Montravers P, Dupont H, Bedos JP, Bret P, Tigecycline Group. Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting. Intensive Care Med. 2014;40:988–97.10.1007/s00134-014-3323-7
   PubMed Web of Science ®Google Scholar
• Esposito S, Noviello S, Leone S. Dalbavancin for the treatment of acute bacterial skin and skin structure. Infez Med. 2015;4:313–7.
   Google Scholar
• Guirao X, Sánchez García M, Bassetti M, Bodmann KF, Dupont H, Montravers P, et al. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intraabdominal infections: an analysis based on five European observational studies. J Antimicrob Chemother. 2013;68(Suppl. 2):37–44.
   Web of Science ®Google Scholar
• Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med. 2013;368:1695–703.10.1056/NEJMoa1206300
   PubMed Web of Science ®Google Scholar
• Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, et al. Randomized controller trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis. 2007;44:178–85.10.1086/510392
   PubMed Web of Science ®Google Scholar
• Miller LG, Tan J, Eells SJ, Benitez E, Radner AB. Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother. 2012;56:1084–6.10.1128/AAC.01608-10
   PubMed Web of Science ®Google Scholar
• Ardelt M, Dittmar Y, Kocijan R, Rödel J, Schulz B, Scheuerlein H, et al. Microbiology of the infected recurrent sacrococcygeal pilonidal sinus. Int Wound J. 2016;13:231–7.10.1111/iwj.2016.13.issue-2
   PubMed Web of Science ®Google Scholar
• Omole F, Simmons BJ, Hacker Y. Management of Bartholin’s duct cyst and gland abscess. Am Fam Physician. 2003;68:135–40.
   PubMed Web of Science ®Google Scholar
• Crotty MP, Krekel T, Burnham CA, Ritchie DJ. New Gram-positive agents: the next generation of oxazolidinones and lipoglycopeptides. J Clin Microbiol. 2016;54(9):2225–32.10.1128/JCM.03395-15
   PubMed Web of Science ®Google Scholar
• Stefani S, Esposito S. Daptomycin, the first cydal antibiotic of a new class active against Gram positive pathogens. Infez Med. 2006;14(4):179–96.
   PubMedGoogle Scholar
• Dunne MW, Talbot GH, Boucher HW, Wilcox M, Puttagunta S. Safety of dalbavancin in the treatment of skin and skin structure infections: a pooled analysis of randomized, comparative studies. Drug Saf. 2016;39(2):147–57.10.1007/s40264-015-0374-9
   PubMed Web of Science ®Google Scholar
• Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J. A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis. 2016;62(5):545–51.10.1093/cid/civ982
   PubMed Web of Science ®Google Scholar
• Scoble PJ, Owens RC Jr, Puttagunta S, Yen M, Dunne MW. Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects. Clin Drug Investig. 2015;35(12):785–93.10.1007/s40261-015-0340-4
   PubMed Web of Science ®Google Scholar
• Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51(8):344–62.10.1067/j.cpsurg.2014.06.001
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Biedenbach DJ, Kazmierczak KM, Stone GG, Sahm DF. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014. Antimicrob Agents Chemother. 2016;60(5):2849–57.10.1128/AAC.02286-15
   PubMed Web of Science ®Google Scholar
• Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund. A Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis. 2014;59(6):851–87.
   PubMed Web of Science ®Google Scholar
• Lo Pardo D, Pezzuti G, Selleri C, Pepe S, Esposisto S. Adjuvant treatment of diabetic foot. Infez Med. 2012;Suppl. 1:35–41.
   Google Scholar
• Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med. 2014;370:2169–79.10.1056/NEJMoa1310480
   PubMed Web of Science ®Google Scholar
• Nathwani D, Dryden M, Garau J. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe Int J Antimicrob Agents. 2016;48:127–36.10.1016/j.ijantimicag.2016.04.023
   PubMed Web of Science ®Google Scholar
• Esposito S, Noviello S, Boccia G, De Simone G, Pagliano P, De Caro F. Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: a comparison of two time periods. Infez Med. 2016;2:137–9.
   Google Scholar
• Palmieri F, Alberici F, Deales A, Furneri G, Menichetti F, Orchi N, et al. Early discharge of infectious disease patients: an opportunity or extra cost for the Italian Healthcare System? Infez Med. 2013;21:182–6.
   Google Scholar
• Nathwani D, Eckmann C, Lawson W, Stephens JM, Macahilig C, Solem CT, et al. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. Clin Microbiol Infect. 2014;20(10):993–1000.10.1111/1469-0691.12632
   PubMed Web of Science ®Google Scholar